| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/19/1997 | WO1997021435A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021434A1 Dietary regimen of nutritional supplements for relief of symptoms of arthritis |
| 06/19/1997 | WO1997021433A1 Method for inhibiting generation of free-radicals |
| 06/19/1997 | WO1997021432A1 Use of bicyclic mono- or diketone derivatives, resulting compounds, and use thereof as a drug for treating inflammation, migraine and shock |
| 06/19/1997 | WO1997021431A1 Cobalt schiff base compounds |
| 06/19/1997 | WO1997021419A1 Dual component tooth whitening dentifrice |
| 06/19/1997 | WO1997021416A2 Glycoconjugates of opiated substances |
| 06/19/1997 | WO1997017434A3 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
| 06/19/1997 | WO1997016549A3 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 06/19/1997 | WO1997016221A3 Genetic induction of receptors for targeted radiotherapy |
| 06/19/1997 | WO1997011666A3 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases |
| 06/19/1997 | WO1997010796A3 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |
| 06/19/1997 | WO1997006662A3 Inverted chimeric and hybrid oligonucleotides |
| 06/19/1997 | WO1996040098A3 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 06/19/1997 | DE19547160A1 Verwendung von Zuckerderivaten als antimikrobiell, antimykotisch und/oder antivirale Wirkstoffe Use of sugar derivatives as antimicrobial, antifungal and / or antiviral agents |
| 06/19/1997 | DE19547105A1 Treatment of dental and nasal problems and herpes infections |
| 06/19/1997 | DE19547022A1 Kovalente Lipid-Phosphonocarbonsäure-Konjugate, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel Covalent lipid phosphonocarboxylic acid conjugates, their preparation and their use as antiviral drugs |
| 06/19/1997 | DE19546698A1 Copolymerisate aus Carbonsäuren und mehrfach olefinisch ungesättigten Carbonsäurederivaten und ihre Verwendung als Verdickungs- oder Dispergiermittel Copolymers of carboxylic acids and poly-olefin-unsaturated carboxylic acid derivatives and their use as thickeners or dispersants |
| 06/19/1997 | DE19546452A1 Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel New Phenylamidinderivate, processes for their Herstelung and their use as medicaments |
| 06/19/1997 | CA2509505A1 Retroviral protease inhibiting compounds |
| 06/19/1997 | CA2273983A1 Process for the preparation of 9-deazaguanine derivatives |
| 06/19/1997 | CA2245509A1 Method for inhibiting generation of free-radicals |
| 06/19/1997 | CA2242929A1 Production and screening process for phytochemical production by plant cell cultures |
| 06/19/1997 | CA2240404A1 Naphthyl glyoxamides as spla2 inhibitors |
| 06/19/1997 | CA2240395A1 Naphthyl acetamides as spla2 inhibitors |
| 06/19/1997 | CA2240279A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
| 06/19/1997 | CA2240183A1 Cobalt schiff base compounds |
| 06/19/1997 | CA2240165A1 Dietary regimen of nutritional supplements for relief of symptoms of arthritis |
| 06/19/1997 | CA2240115A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240111A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240108A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240048A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240024A1 Nuclear receptor ligands and ligand binding domains |
| 06/19/1997 | CA2239991A1 Modified vegf antisense oligonucleotides |
| 06/19/1997 | CA2239910A1 Novel steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs |
| 06/19/1997 | CA2239908A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 06/19/1997 | CA2239873A1 Antifungal proteins |
| 06/19/1997 | CA2239731A1 Antifungal proteins |
| 06/19/1997 | CA2239508A1 Naphthyl-substituted benzimidazole derivatives as anticoagulants |
| 06/19/1997 | CA2239293A1 Assay for and uses of peptide hormone receptor ligands |
| 06/19/1997 | CA2239058A1 Anti-cocaine vaccine |
| 06/19/1997 | CA2238977A1 Retroviral protease inhibiting compounds |
| 06/19/1997 | CA2238975A1 New use for losartan |
| 06/19/1997 | CA2238711A1 3-benzylaminopyrrolidines and piperidines as tachykinin receptor antagonists |
| 06/19/1997 | CA2238298A1 Quinoline derivatives |
| 06/19/1997 | CA2238175A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 06/19/1997 | CA2237058A1 Copolymers of carboxylic acids and multiply olefinically unsaturated carboxylic acid derivatives and their use as thickeners and dispergents |
| 06/19/1997 | CA2236335A1 Agents for promoting bone formation |
| 06/19/1997 | CA2212371A1 Novel compounds and methods for treating multiple sclerosis |
| 06/19/1997 | CA2211596A1 Glycoconjugates of opiated substances |
| 06/19/1997 | CA2211161A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness |
| 06/19/1997 | CA2211075A1 Carbapenem-3-carboxylic acid ester derivatives |
| 06/18/1997 | EP0779365A2 Methods to introduce nucleic acid into cells for therapeutic and diagnostic uses |
| 06/18/1997 | EP0779291A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/18/1997 | EP0779288A1 Substituted chromanylsulfonyl(thio)ureas, process for their preparation, their use in pharmaceutical compositions and preparations containing them |
| 06/18/1997 | EP0779284A1 Novel 2-naphthamide derivatives and their use in therapy as D3 receptor agonists |
| 06/18/1997 | EP0779282A1 Thiomorpholinone compounds for treating multiple sclerosis |
| 06/18/1997 | EP0779281A1 Isoxazoles |
| 06/18/1997 | EP0779279A1 Bicyclic heterocycles |
| 06/18/1997 | EP0779276A1 Indolyl-substituted phenylacetic acid derivatives |
| 06/18/1997 | EP0779273A1 Naphthyl glyoxamides as sPLA2 inhibitors |
| 06/18/1997 | EP0779271A1 Naphthyl acetamides as sPLA2 inhibitors |
| 06/18/1997 | EP0779075A1 Use of 3-alpha-hydroxy-5alpha-androsta-16-ene as pharmaceutical |
| 06/18/1997 | EP0779074A1 Protective agent for organ or tissue |
| 06/18/1997 | EP0779073A1 Method and compositions for topical therapy of postoperative and posttraumatic pain |
| 06/18/1997 | EP0778851A1 Method for controlling o-desulfation of heparin and compositions produced thereby |
| 06/18/1997 | EP0778846A1 Spirostanyl glycosidal crystals |
| 06/18/1997 | EP0778845A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids |
| 06/18/1997 | EP0778844A1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes |
| 06/18/1997 | EP0778843A1 Intermediates for dinucleotide and oligonucleotide analogues |
| 06/18/1997 | EP0778839A1 Novel phosphane oxides, method of preparing them and drugs containing these compounds |
| 06/18/1997 | EP0778836A1 Substituted 9-alkyladenines |
| 06/18/1997 | EP0778835A1 7-azabicyclo 2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands |
| 06/18/1997 | EP0778834A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 06/18/1997 | EP0778833A1 Endothelin receptor antagonists |
| 06/18/1997 | EP0778831A1 Morpholine derivatives and their use as therapeutic agents |
| 06/18/1997 | EP0778829A1 Novel 4-aminopyridazines, method of preparing them and drugs containing these compounds |
| 06/18/1997 | EP0778820A1 Neurotrophic and antiproliferative compounds |
| 06/18/1997 | EP0778780A1 Capsular polysaccharide immunomodulator |
| 06/18/1997 | EP0778776A1 Hyaluronic acid and derivatives for modulation of cellular activity |
| 06/18/1997 | EP0778775A1 Cosolvent parenteral formulation of tirilazad |
| 06/18/1997 | EP0778774A2 New use of prostaglandins |
| 06/18/1997 | EP0778773A1 Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes |
| 06/18/1997 | EP0778772A1 Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides |
| 06/18/1997 | EP0778771A1 Topical ketoconazole emulsions |
| 06/18/1997 | EP0778770A1 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer |
| 06/18/1997 | EP0778769A1 Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system |
| 06/18/1997 | EP0778768A1 Formulations and methods for providing prolonged local anesthesia |
| 06/18/1997 | EP0778767A2 Delivery of solid drug compositions |
| 06/18/1997 | EP0778731A1 Ionene polymers containing biologically-active anions |
| 06/18/1997 | EP0731812A4 POLY-beta-1-4-N-ACETYLGLUCOSAMINE |
| 06/18/1997 | EP0710110A4 Rapamycin conjugates and antibodies |
| 06/18/1997 | EP0701562B1 Unsaturated phosphonates derivatives of purines and pyrimidines |
| 06/18/1997 | EP0687257B1 4-amino-2-(hetero)aryl-butanamides useful as 5-ht1a-antagonists |
| 06/18/1997 | EP0675897B1 New steroids |
| 06/18/1997 | EP0662953B1 Novel vitamin d analogues |
| 06/18/1997 | EP0616609B1 Nitroaniline derivatives and their use as antitumor agents |
| 06/18/1997 | EP0559706B1 2$g(b),19-METHYLENEAMINO BRIDGED STEROIDS AS AROMATASE INHIBITORS |
| 06/18/1997 | EP0538314B1 Indano pyrrolidine carbamates |
| 06/18/1997 | EP0536363B1 Novel heparin derivatives and process for the preparation thereof |